Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · IEX Real-Time Price · USD
0.760
0.00 (0.00%)
Apr 11, 2024, 4:30 PM EDT - Market closed
0.00%
Market Cap 78.01M
Revenue (ttm) 75.80M
Net Income (ttm) -92.20M
Shares Out 102.64M
EPS (ttm) -0.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,585
Open 0.730
Previous Close 0.760
Day's Range 0.730 - 0.805
52-Week Range 0.572 - 3.250
Beta 0.23
Analysts n/a
Price Target n/a
Earnings Date May 28, 2024

About BNR

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colo... [Read more]

Sector Healthcare
IPO Date Jun 12, 2020
Employees 1,138
Stock Exchange NASDAQ
Ticker Symbol BNR
Full Company Profile

Financial Performance

In 2023, BNR's revenue was 537.44 million, a decrease of -4.58% compared to the previous year's 563.24 million. Losses were -653.69 million, -32.69% less than in 2022.

Financial numbers in CNY Financial Statements

News

Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results

GUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation s...

16 days ago - GlobeNewsWire

Burning Rock Announces Receipt of Notification from NASDAQ

GUANGZHOU, China, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

3 months ago - GlobeNewsWire

Burning Rock Announces Results of 2023 Annual General Meeting

GUANGZHOU, China, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation s...

4 months ago - GlobeNewsWire

Burning Rock Reports Third Quarter 2023 Financial Results

GUANGZHOU, China, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

4 months ago - GlobeNewsWire

Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023

GUANGZHOU, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation s...

5 months ago - GlobeNewsWire

Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

GUANGZHOU, China, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

5 months ago - GlobeNewsWire

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics

GUANGZHOU, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that the Company and Boehringer Inge...

5 months ago - GlobeNewsWire

Burning Rock Received Breakthrough Device Designation from China's NMPA for its Multi-Cancer Early Detection Test

GUANGZHOU, China, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that followed an earlier Breakthroug...

6 months ago - GlobeNewsWire

Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell

GUANGZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is delighted to announce that our personalized Minimal Res...

7 months ago - GlobeNewsWire

Burning Rock Reports Second Quarter 2023 Financial Results

GUANGZHOU, China, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

8 months ago - GlobeNewsWire

Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023

GUANGZHOU, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

9 months ago - GlobeNewsWire

Burning Rock Announces Resignation and Appointment of Directors

GUANGZHOU, China, June 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

10 months ago - GlobeNewsWire

Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine

GUANGZHOU, China, June 08, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that our flagship comprehensive geno...

11 months ago - GlobeNewsWire

Burning Rock Reports First Quarter 2023 Financial Results

GUANGZHOU, China, May 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation seq...

11 months ago - GlobeNewsWire

Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023

GUANGZHOU, China, April 27, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation s...

1 year ago - GlobeNewsWire

Burning Rock Publishes 2022 Annual Report on Form 20-F

GUANGZHOU, China, April 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation s...

1 year ago - GlobeNewsWire

Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results

GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation s...

1 year ago - GlobeNewsWire

Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023

GUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation s...

1 year ago - GlobeNewsWire

Burning Rock provides an update on 2022 revenue guidance

GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

1 year ago - GlobeNewsWire

Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology...

1 year ago - GlobeNewsWire

Burning Rock Reports Third Quarter 2022 Financial Results

GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation se...

1 year ago - GlobeNewsWire

Admission to Trading on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WO...

1 year ago - GlobeNewsWire

Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WO...

1 year ago - GlobeNewsWire

Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022

GUANGZHOU, China, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS...

1 year ago - GlobeNewsWire

Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WO...

1 year ago - GlobeNewsWire